Event Details
February 25, 2019
Description
Distribution of a memo by the chief physician executive of Intermountain Healthcare lifting a directive against recommending cannabis treatments.
Participants (2)
| Name | Type | Mentions | |
|---|---|---|---|
| Chief Physician Executive of Intermountain Healthcare | person | 0 | View Entity |
| Network of providers | person | 0 | View Entity |
Source Documents (1)
HOUSE_OVERSIGHT_024880.jpg
Market Research Report / Industry Analysis
• 1.68 MB
This document is page 64 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the healthcare payor and provider perspectives on CBD oils and medical marijuana, specifically discussing reimbursement challenges with CMS and commercial insurers, as well as policy shifts at Intermountain Healthcare in Utah. The document bears a 'HOUSE_OVERSIGHT_024880' Bates stamp, indicating it was part of a document production for a House Oversight Committee investigation.
Event Metadata
Type
Unknown
Location
Utah
Significance Score
5/10
Participants
2
Source Documents
1
Extracted
2025-11-21 00:55
Additional Data
Source
HOUSE_OVERSIGHT_024880.jpg
Date String
Recent (relative to Feb 25, 2019)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein event